A Phase II Study of Decitabine In Advanced Chronic Myelomonocytic Leukemia (CMML)

被引：0

作者：

Braun, Thorsten ^{[1
]}

Droin, Nathalie ^{[1
]}

de Renzis, Benoit ^{[1
]}

Dreyfus, Francois ^{[1
]}

Laribi, Kamel ^{[1
]}

Bouabdallah, Krimo ^{[1
]}

Charbonnier, Aude ^{[1
]}

Cordonnier, Catherine ^{[1
]}

Lafon, Ingrid ^{[1
]}

Recher, Christian ^{[1
]}

Vey, Norbert ^{[1
]}

Bastie, Jean-Noel M. ^{[1
]}

Besancon, A. ^{[1
]}

Beyne-Rauzy, Odile ^{[1
]}

Joly, Bertrand ^{[1
]}

Jourdan, Eric ^{[1
]}

Legros, Laurence ^{[1
]}

Marjanovic, Zora ^{[1
]}

Petitdidier, Charlotte ^{[1
]}

Royer, Bruno ^{[1
]}

Sanhes, Laurence ^{[1
]}

Tertian, Gerard ^{[1
]}

Vaida, Ioana ^{[1
]}

Vallantin, Xavier ^{[1
]}

Vekhoff, Anne ^{[1
]}

Milic, Marina ^{[1
]}

Itzykson, Raphael ^{[1
]}

Gardin, Claude ^{[1
]}

Ades, Lionel ^{[1
]}

Fenaux, Pierre ^{[1
]}

Solary, Eric ^{[1
]}

机构：

[1] Grp Francophone Myelodysplasies, Bobigny, France

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：780 / 781

页数：2

共 50 条

[1] Efficacy of decitabine in advanced chronic myelomonocytic leukemia (CMML) patients
Santini, V.
Allione, B.
Lunghi, M.
Levis, A.
Poloni, A.
Angelucci, E.
Onida, F.
Terenzi, A.
Finelli, C.
Ferrero, D.
LEUKEMIA RESEARCH, 2013, 37 : S17 - S17
[2] Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).
Wijermans, P. W.
Luebbert, Michael
Baer, Maria R.
Slack, James L.
BLOOD, 2006, 108 (11) : 756A - 757A
[3] Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
Wijermans, P. W.
Rueter, B.
Baer, M. R.
Slack, J. L.
Saba, H. I.
Luebbert, M.
LEUKEMIA RESEARCH, 2008, 32 (04) : 587 - 591
[4] Decitabine In Advanced Chronic Myelomonocytic Leukemia
Santini, Valeria
Allione, Bernardino
Levis, Alessandro
Gioia, Daniela
Lunghi, Mania
Poloni, Antonella
Cilloni, Daniela
Zini, Gina
Sanna, Alessandro
Rossi, Alessia
Terenzi, Adelmo
Angelucci, Emanuele
Finelli, Carlo
Onida, Francesco
Rossi, Giuseppe
Ferrero, Dario
Saglio, Giuseppe
Masiera, Elisa
BLOOD, 2013, 122 (21)
[5] MUTATIONAL ANALYSIS AND LONG TERM OUTCOME IN ADVANCED CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) TREATED BY DECITABINE: AN UPDATE OF THE GFM-CMML-2007 PHASE II TRIAL
Braun, T.
Itzykson, R.
Droin, N.
Renneville, A.
de Renzis, B.
Dreyfus, F.
Laribi, K.
Bouabdallah, K.
Cordonnier, C.
Recher, C.
Vey, N.
Bastie, J. N.
Beyne-Rauzy, O.
Jolie, B.
Jourdan, E.
Legros, L.
Marjanovic, Z.
Sanhes, L.
Tertian, G.
Vaida, I.
Gardin, C.
Ades, L.
Solary, E.
Fenaux, P.
HAEMATOLOGICA, 2014, 99 : 500 - 500
[6] A Phase II Trial of Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Thrombocytopenia
Itzykson, Raphael
Lambert, Jerome
Barbieri, Daniela
Gruson, Berengere
Thepot, Sylvain
Braun, Thorsten
Vey, Norbert
Delaunay, Jacques
Legros, Laurence
Lejeune, Julie
Sapena, Rosa
Droin, Nathalie
Porteu, Francoise
Solary, Eric
Fenaux, Pierre
BLOOD, 2017, 130
[7] Decitabine induces high response rates in patients with chronic myelomonocytic leukemia (CMML).
Jabbour, Elias
O'Brien, Susan
Ravandi-Kashani, Farhad
Cortes, Jorge
Borthakur, Gautam
Verstovsek, Srdan
Garcia-Manero, Guillermo
Giles, Francis
Zanoria, Lourdes
Davisson, Jan
Issa, Jean-Pierre
Kantarjian, Hagop M.
BLOOD, 2006, 108 (11) : 750A - 750A
[8] Chronic myelomonocytic leukemia (CMML)
Geissler, Klaus
WIENER MEDIZINISCHE WOCHENSCHRIFT, 2023, 173 (1-2) : 1 - 2
[9] Chronic myelomonocytic leukemia (CMML)
Klaus Geissler
Wiener Medizinische Wochenschrift, 2023, 173 : 1 - 2
[10] Hypomethylation induction and molecular response after decitabine therapy in chronic myelomonocytic leukemia (CMML).
Oki, Yasuhiro
Jelinek, Jaroslav
Kantarjian, Hagop M.
Issa, Jean-Pierre J.
BLOOD, 2006, 108 (11) : 658A - 658A

← 1 2 3 4 5 →